DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of DICE Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. DICE Therapeutics Inc market cap is $2.27B.
What is the 52-week high for DICE Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. DICE Therapeutics Inc 52 week high is $47.90 as of September 10, 2025.
What is the 52-week low for DICE Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. DICE Therapeutics Inc 52 week low is $15.08 as of September 10, 2025.
What is DICE Therapeutics Inc stock price today?
DICE Therapeutics Inc stock price today is $47.55.
What was DICE Therapeutics Inc stock price yesterday?
DICE Therapeutics Inc stock price yesterday was $47.52.
What is the PE ratio of DICE Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. DICE Therapeutics Inc’s P/E ratio is -20.33.
What is the Price-to-Book ratio of DICE Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. DICE Therapeutics Inc P/B ratio is 4.3780.
What is DICE Therapeutics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. DICE Therapeutics Inc's EBITDA is -14.44.
What is the 50-day moving average of DICE Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. DICE Therapeutics Inc 50-day moving average is $43.48.
